TriSalus Life Sciences, Inc. (TLSI) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 68.14M | 32.24M | 33.33M | 38.08M | 25.1M | 20.67M | 23.81M | 27.94M | 13.19M | 20.86M | 29.04M | 12.38M |
| Cash & Short-Term Investments | 56.55M | 20.44M | 22.69M | 26.49M | 13M | 8.53M | 11.29M | 16.48M | 3.97M | 11.78M | 21.38M | 3.9M |
| Cash Only | 56.55M | 20.44M | 22.69M | 26.49M | 13M | 8.53M | 11.29M | 16.48M | 3.97M | 11.78M | 21.38M | 3.9M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 5.21M | 6.56M | 5M | 5.57M | 5.45M | 5.09M | 4.91M | 4.71M | 4.28M | 3.55M | 3.05M | 2.09M |
| Days Sales Outstanding | 59.53 | 40.26 | 42.04 | 44.73 | 51.74 | 55.68 | 60.2 | 55.5 | 55.18 | 53.12 | 45.58 | 36.36 |
| Inventory | 3.78M | 3.08M | 3.28M | 3.81M | 4.16M | 4.05M | 4M | 3.44M | 2.91M | 2.54M | 1.63M | 1.52M |
| Days Inventory Outstanding | 250.79 | 165.86 | 170.94 | 201.22 | 247.12 | 304.41 | 340.97 | 317.1 | 255.76 | 329.9 | 246.09 | 191.14 |
| Other Current Assets | 2.59M | 0 | 2.37M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Total Non-Current Assets | 2.84M | 3.09M | 3.13M | 3.23M | 3.53M | 3.3M | 3.67M | 4.49M | 4.7M | 3.74M | 4.51M | 4.43M |
| Property, Plant & Equipment | 2.77M | 2.67M | 2.72M | 2.81M | 3.1M | 2.88M | 3.25M | 2.95M | 3.16M | 3.27M | 3.15M | 3.21M |
| Fixed Asset Turnover | 3.27x | 4.90x | 4.18x | 3.79x | 3.06x | 2.70x | 2.37x | 2.41x | 2.01x | 1.78x | 1.63x | 1.39x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.11M | 1.11M | 1.13M | 997K | 858K |
| Long-Term Investments | 0 | 400K | 0 | 0 | 350K | 350K | 0 | 350K | 350K | 0 | 0 | 0 |
| Other Non-Current Assets | 69K | 18K | 419K | 419K | 74K | 73K | 424K | 74K | 74K | -661K | 367K | 367K |
| Total Assets | 70.98M | 35.33M | 36.46M | 41.32M | 28.63M | 23.97M | 27.48M | 32.43M | 17.89M | 24.6M | 33.55M | 16.81M |
| Asset Turnover | 0.17x | 0.37x | 0.30x | 0.32x | 0.35x | 0.32x | 0.25x | 0.29x | 0.30x | 0.20x | 0.21x | 0.25x |
| Asset Growth % | 147.96% | 47.39% | 32.7% | 27.4% | 60.01% | -2.55% | -18.11% | 92.92% | -9.84% | 11.83% | 42.21% | -93.29% |
| Total Current Liabilities | 11.79M | 11.5M | 10.91M | 9.32M | 11.75M | 10.23M | 9.92M | 12M | 14.39M | 14.69M | 9.3M | 32.19M |
| Accounts Payable | 0 | 3M | 0 | 1.9M | 2.81M | 2.27M | 1.45M | 1.98M | 2.35M | 3.39M | 1.9M | 4.3M |
| Days Payables Outstanding | - | 156.74 | - | 118.88 | 152.91 | 140.72 | 156.78 | 215.73 | 268.92 | 418.11 | 483.9 | 516.06 |
| Short-Term Debt | 218K | 167K | 129K | 0 | 0 | 0 | 0 | 323K | 363K | 351K | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 11.57M | 8.23M | 10.78M | 1.97M | 3.62M | 383K | 3.32M | 6.76M | 6.6M | 6.29M | 427K | 18.4M |
| Current Ratio | 5.78x | 2.80x | 3.05x | 4.08x | 2.14x | 2.02x | 2.40x | 2.33x | 0.92x | 1.42x | 3.12x | 0.38x |
| Quick Ratio | 5.46x | 2.54x | 2.75x | 3.68x | 1.78x | 1.63x | 2.00x | 2.04x | 0.71x | 1.25x | 2.95x | 0.34x |
| Cash Conversion Cycle | - | 49.37 | - | 127.07 | 145.95 | 219.36 | 244.39 | 156.88 | 42.01 | -35.09 | -192.23 | -288.56 |
| Total Non-Current Liabilities | 46.39M | 57.69M | 52.28M | 51.42M | 51.24M | 39.64M | 37.99M | 44.58M | 38.42M | 36.98M | 15.76M | 1.67M |
| Long-Term Debt | 34.27M | 34.27M | 33.99M | 32.27M | 31.7M | 22.08M | 21.68M | 21.29M | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 1.26M | 1.3M | 1.33M | 1.51M | 1.15M | 1.22M | 1.24M | 1.32M | 1.41M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 12.12M | 23.42M | 18.28M | 17.88M | 18.24M | 16.22M | 14.81M | 22.14M | 37.2M | 35.73M | 14.44M | 262K |
| Total Liabilities | 58.17M | 69.19M | 63.19M | 60.74M | 62.99M | 49.87M | 47.91M | 56.58M | 52.81M | 51.66M | 25.07M | 33.86M |
| Total Debt | 34.49M | 34.44M | 34.12M | 33.66M | 33.12M | 23.63M | 23.45M | 22.76M | 1.58M | 1.59M | 1.7M | 1.79M |
| Net Debt | -22.07M | 14M | 11.44M | 7.17M | 20.12M | 15.1M | 12.16M | 6.28M | -2.39M | -10.18M | -19.69M | -2.11M |
| Debt / Equity | 2.69x | - | - | - | - | - | - | - | - | - | 0.20x | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -5.86x | -5.72x | -6.40x | -4.83x | -7.58x | -8.47x | -1.10x | -3.93x | -4404.33x | -11835.00x | -355.25x | -3489.25x |
| Total Equity | 12.81M | -33.86M | -26.73M | -19.42M | -34.37M | -25.89M | -20.43M | -24.15M | -34.92M | -27.07M | 8.49M | -17.05M |
| Equity Growth % | 137.26% | -30.77% | -30.79% | 19.57% | 1.58% | 4.33% | -340.74% | -41.64% | -748.68% | -119.61% | -15.8% | -107.15% |
| Book Value per Share | 0.24 | -0.72 | -0.62 | -0.59 | -1.20 | -0.98 | -0.77 | -1.01 | -1.50 | -1.02 | 0.32 | -0.64 |
| Total Shareholders' Equity | 12.81M | -33.86M | -26.73M | -19.42M | -34.37M | -25.89M | -20.43M | -24.15M | -34.92M | -27.07M | 8.49M | -17.05M |
| Common Stock | 5K | 4K | 4K | 3K | 3K | 3K | 3K | 2K | 2K | 2K | 2K | 18K |
| Retained Earnings | -329.04M | -330.58M | -320.97M | -298.21M | -289.92M | -279.55M | -269.44M | -265.93M | -261.6M | -249.5M | -212.87M | -211.58M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1K | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |